Menu
Not yet recruiting NCT06614218

MIMS® Retrospective Chart Review

— Observational Open Angle Glaucoma

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Minimally Invasive Micro Sclerostomy.
Who it may be relevant to
Registry conditions: Open Angle Glaucoma. Basic parameters: 40 years — 85 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Armenia
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Minimally Invasive Micro Sclerostomy (MIMS®) Retrospective Chart Review

Overview

This is a post-market clinical follow-up, retrospective chart review of MIMS® surgical procedures conducted during time period between Sep 2023 and May 2025.

Interventions

  • Device Minimally Invasive Micro Sclerostomy
    The MIMS® procedure uses the proprietary MIMS® device, which creates a sclerostomy in the eye.

Primary outcome measures

  • Change in IOP from medicated baseline at 12 months post-MIMS® surgery [Time frame: Medicated baseline at 12 months post-MIMS® surgery]
  • Change in the number of topical IOP-lowering medications from medicated baseline at 12 months post-MIMS® surgery [Time frame: Medicated baseline at 12 months post-MIMS® surgery]
  • Success rate at 12 months post-MIMS® surgery [Time frame: 12 months post-MIMS® surgery]

Eligibility criteria

Inclusion criteria

  • Eye treated with MIMS® Device as a standalone procedure
  • MIMS® surgery was performed between 27 Sep 2023 and 30 April 2024

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Study design

Observational model
Cohort

Study locations

Armenia · 1 center
  • S. Malayan Eye Center — Yerevan

Identifiers

NCT: NCT06614218 · MMS-EEU-9

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗